Hologic Inc.
Board Member Retirements Announced by Hologic, Inc.
Summary
On January 6, 2025, Hologic, Inc. announced that Sally W. Crawford and Scott T. Garrett, both members of the Board of Directors, will not stand for re-election at the Company's 2025 Annual Meeting due to retirement and age retirement respectively. Ms. Crawford's decision marks her retirement after more than 17 years of service, while Mr. Garrett's non-nomination is due to reaching the retirement age set in the Corporate Governance Guidelines. The Board expressed gratitude for their contributions.
Profitelligence Alerts
Get alerts for HOLX
Be first to know when Hologic Inc. files with the SEC.
Filing Categories
Advertisement
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Official SEC Documents
Advertisement